Dr. Osuji

Contributions

Biliverdin Reductase B Plays Antioxidant Role in RBCs

BlvrB is an important antioxidant in mature red blood cells. It is especially helpful in preventing hemolytic anemia in G6PD-deficient individuals. Biliverdin reductase B (BlvrB) is the fourth-most abundant enzyme in red blood cells (RBCs) and is also present in many other tissues. Existing literature on heme metabolism and bilirubin-related pathologies has predominantly focused on...

Affordable Care Act and Prostate Cancer Treatment Delays

Broader systemic issues may still affect healthcare accessibility for certain populations. Despite the implementation of the Affordable Care Act, disparities remain in the time taken to initiate prostate cancer treatment.  The Affordable Care Act aimed to reduce healthcare disparities. Prostate cancer treatment delays increased despite the Affordable Care Act. Non-White and Medicaid-insured men face higher...

MRI-Measured PPAT Volume: A Key Prognostic Indicator for Prostate Cancer

New research examines the prognostic value of periprostatic adipose tissue volume measured by MRI in patients undergoing laparoscopic radical prostatectomy for prostate cancer. These MRI determinations have become invaluable for providing deeper insights into potential treatment outcomes and the progression of the cancer.  MRI-measured periprostatic adipose tissue volume showed a strong correlation with prostate cancer...

Precision Medicine Disparities in Prostate Cancer Treatment

Prostate cancer precision medicine offers great potential, providing tailored approaches that maximize patient benefits. However, disparities remain, particularly among Black men, who may face unequal access and outcomes.  Black men with metastatic castration-resistant prostate cancer show higher frequencies of certain genetic markers than White men. Despite these actionable molecular markers, Black men are less likely...

Dupilumab Beneficial for Adults With Prurigo Nodularis

For adults with prurigo nodularis (PN), dupilumab, a fully human monoclonal antibody that blocks the shared receptor component for interleukin (IL)-4 and IL-13, demonstrates clinically meaningful and significant improvements in itch and skin lesions in two phase 3 trials (LIBERTY-PN PRIME and PRIME2), according to a study published online May 4 in Nature Medicine. Gil...

Multiple Myeloma Webcast: Understanding MM and its Impact

In this exclusive MD Newsline webcast Hematology-Oncology Specialists Dr. Mouhammed Kelta and Dr. Shaina Rozell discuss health disparities in Multiple Myeloma. View the webcast here.

National Medical Association Announces Three-Year Partnership Supporting Sickle Cell Endeavors by St. Jude Children’s Research Hospital

SILVER SPRING, MD – The National Medical Association (NMA) is hosting its 121st Annual Convention and Scientific Assembly, themed “Accelerating the March Toward Health Equity,” July 29 – August 2, 2023, in the culturally rich city of New Orleans, LA, at the Hyatt Regency Hotel. This annual conference is acclaimed as the nation’s foremost forum on medical science and African...

Atopic Dermatitis Webcast: Understanding AD and its Impact

In this exclusive MD Newsline webcast Dr. Edidong Kaminska & Dr. Beth Adams will discuss details behind diagnosing and treating Atopic Dermatitis in patients of color. Register here to view the webcast. Dr. Edidong Kaminska is a board-certified dermatologist with over 10 years of experience. She is a graduate of Wake Forest University School of...

Dr. Mohiba Tareen on Disparities in Atopic Dermatitis

Dr. Mohiba Tareen is a nationally acclaimed board certified dermatologist and Founder and Medical Director of Tareen Dermatology. With three locations and over 100 staff, Dr. Tareen and her team provide cutting-edge yet caring dermatologic care to patients. As an expert dermatologist for WebMD and WikiHow, Dr. Tareen is frequently interviewed by the media for...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.